RC

Rekhakumari Chandrabhushan Singh

Active Director Director DIN 08548231
DIN 08548231 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Rekhakumari Chandrabhushan Singh

Data last updated:

Rekhakumari Chandrabhushan Singh is a Director at Glonest Pharma Private Limited (since 2019). The company operates in Healthcare. Glonest Pharma Private Limited reported revenue of ₹1.70 Cr (FY 2025).

DIN 08548231
Primary Designation Director
Industry Healthcare
First Appointment 28 Aug 2019
Oldest Company Age 7 yrs
Largest company Glonest Pharma Private Limited · ₹1.70 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glonest Pharma Private Limited U51909MH2019PTC329852
Director28 Aug 20192019₹1.70 Cr (FY 2025)Active

Board colleagues of Rekhakumari Chandrabhushan Singh

Directorship timeline

Open interactive timeline →
Glonest Pharma Private Limited
Premium access

Shareholding and investment profile for Rekhakumari Chandrabhushan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekhakumari Chandrabhushan Singh

Rekhakumari Chandrabhushan Singh currently holds 1 directorship: Glonest Pharma Private Limited (Director, since 28 Aug 2019, revenue ₹1.70 Cr (FY 2025)).

Rekhakumari Chandrabhushan Singh was first appointed on 28 Aug 2019 as Director at Glonest Pharma Private Limited.

The current boards of Rekhakumari Chandrabhushan Singh's companies include Ashok Kumar (Glonest Pharma Private Limited), Harish Chandra Kaleshwar Prajapati (Glonest Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available